ThermoMind
ThermoMind36About
What does ThermoMind do?
ThermoMind aims to improve breast cancer survival rates by enabling early detection in women of all ages and breast densities. Their technology utilizes high-resolution infrared cameras to capture thermal images, offering a risk-free and non-contact screening modality.
What is ThermoMind's revenue?
StartupHub estimates ThermoMind's annual revenue at $1.3M (range $791K to $3.0M, 68% confidence), based on comparable companies in the sector.
When was ThermoMind founded?
ThermoMind was founded in 2022.
What industry does ThermoMind operate in?
ThermoMind operates in Healthcare, Breast Cancer, HealthTech, MedTech, Biotech, AI-Driven Drug Discovery.
How many employees does ThermoMind have?
ThermoMind has approximately 7 people on record.
What is ThermoMind's current status?
ThermoMind's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.